Bartosz Janikowski, MD

Senior Vice President, Medical Sciences

Bartosz Janikowski, MD, Senior Vice President, Medical Sciences at Worldwide Clinical Trials, is a board-certified psychiatrist and psychotherapist with more than two decades of clinical experience, 25 years in research and development in many different indications across psychiatry, neurology, pain and rare CNS diseases. Dr Janikowski provides expert insights into design, implementation and analysis of neuroscience study data as we all as provides leaership and mentoring to Worldwide medical staff. Having served as a medical advisor to multiple clinical trials and worked with patients from adult and pediatric populations, he values patient’s and clinical site’s contribution to clinical investigations.

Ask Dr. Janikowski a question

Submit an RFP. Ask a Question

Dr. Janikowski manages and coordinates all the activities of the Medical Affairs Neuroscience group across all therapeutic areas provided to Worldwide’s clients. During his time as investigator and co-investigator, while head of an adult general psychiatry department in a large psychiatric hospital site, and in his private practice, Dr. Janikowski’s main areas of research interest were schizophrenia, affective disorders anxiety, and other neuroscience-related disorders.

Prior to his start at Worldwide, he served as Vice President, Global Neuroscience Head, Medical and Scientific Affairs, and was responsible for creation of an international medical affairs team and direct supervision of all medical monitoring and scientific services delivered to external and internal clients. He also played an integral role in clients’ and KOLs’ relationship management and served as Medical Advisor for numerous trials in his capacity of the neuroscience leader in MDD, anxiety, bipolar disorders, schizophrenia, dementias MCI, and other neurology studies. In addition to trials within adult populations, Dr. Janikowski gained invaluable experience and expertise in the design and delivery of studies within children and adolescents in various psychiatric indications.

Dr. Janikowski has been extensively involved in CNS drug development program designs, protocol developments, medical and safety management of global clinical studies, and CNS raters’ training and qualification programs. Dr. Janikowski’s areas of special interest include schizophrenia, mood disorders, anxiety disorders, clinical studies design, and implementation of psychometric assessments.

Dr. Janikowski holds a doctorate from Charles University, Prague, Czechia.

Want to learn more about Worldwide Clinical Trials?